Identification of the messenger RNA for human cutaneous fatty acid- binding protein as a metastasis inducer

Cancer Research

Volumn 60, Issue 9, 2000, Pages 2390-2398

  Jing, Chun ^a   Beesley, Carol ^a   Foster, Christopher S ^a   Rudland, Philip S ^a   Fujii, Hiroshi ^c   Ono, Terno ^c   Chen, Haijuan ^b   Smith, Paul H ^a   Ke, Youqiang ^a,d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c NIIGATA UNIVERSITY   (Japan)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; MESSENGER RNA;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; METASTASIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; RAT; SOUTHERN BLOTTING;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CARRIER PROTEINS; DNA, COMPLEMENTARY; FATTY ACID-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MYELIN P2 PROTEIN; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PROSTATE; PROSTATIC NEOPLASMS; RATS; RATS, INBRED WF; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0034194342     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hart, I. R., and Saini, A. Biology of tumour metastasis. Lancet, 339: 1453-1457, 1992.
2. Dong, J., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. Kail, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC), 268: 884-886, 1995.
3. Lloyd, B. H., Platt-Higgins, A., Rudland, P. S., and Barraclough, R. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene, 17: 465-473, 1998.
4. Sager, R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc. Natl. Acad. Sci. USA, 94: 952-955, 1997.
5. Ke, Y., Rudland, P. S., Jing, C., Smith, P. H., and Foster, C. S. Systematic differential display: a strategy for a complete assessment of differential gene expression. Anal. Biochem., 269: 201-204, 1999.
6. Ke, Y., Jing, C., Rudland, P. S., Smith, P., and Foster, C. S. Systematic comparison of differential gene expression through analysing the cDNA fragments in protein-coding region. Nucleic Acids Res., 27: 912-914, 1999.
7. Madsen, P., Rasmussen, H. H., Leffers, H., Honore, B., and Celis, J. E. Molecular-cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty-acid binding-protein [pa-fabp]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty-acid binding-proteins. J. Investig. Dermatol., 99: 299-305, 1992.
8. Dunnington, D., Hughes, C. M., Monaghan, P., and Rudland, P. S. Phenotypic instability of rat mammary epithelial cells. J. Natl. Cancer Inst., 71: 1227-1240, 1983.
9. Cussenot, O., Berthon, P., Berger, R., Mowszowicz, I., Faille, A., Hojman, F., Teillac, P., Leduc A., and Calvo, F. Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J. Urol., 146: 881-886, 1991.
10. Cussenot, O., Berthon, P., Cochandpriollet, S., Maitland, N. J., and Leduc, A. Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections. Exp. Cell Res., 214: 83-92, 1994.
11. Berthon, P., Cussenot, O., Hopwood, I., Leduc, A., and Maitland, N. J. Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells: differentiation pattern of nontumorigenic cell lines. Int. J. Oncol., 6: 333-343, 1995.
12. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983.
13. Kaighn, M. E., Lechner, J. F., Narayan, K. S., and Jones, L. W. Prostate carcinoma: tissue culture cell lines. Natl. Cancer Inst. Monogr., 49: 17-21, 1978.
14. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., and Paulson, D. F. Isolation of human prostate carcinoma cell line (Du-145). Int. J. Cancer, 21: 274-281, 1978.
15. Rudland, P. S. Stem cells and the development of mammary cancers in rats and in humans. Cancer Metastasis Res., 6: 55-83, 1987.
16. Soule, H. D. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1413, 1973.
17. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and Mcewan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
18. Dunnington, D. J., Kim, U., Hughes, C. M., Monaghan, P., and Rudland, P. S. Loss of myoepithelial cell characteristics in metastasizing rat mammary tumors relative to their nonmetastasizing counterparts. Cancer Res., 44: 5338-5346, 1984.
19. Coombs, L. M., Pigott, D., Proctor, A., Eydmann, M., Denner, J., and Knowles, M. A. Simultaneous isolation of DNA, RNA, and antigenic protein exhibiting kinase activity from small tumor samples using guanidine isothiocyanate. Anal. Biochem., 188: 338-343, 1990.
20. Jamieson, S., Barraclough, R., and Rudland, P. S. Generation of metastatic variants by transfection of a non-metastatic rat mammary epithelial cell line with DNA from metastatic rat mammary cell lines. Pathobiology, 58: 329-342, 1990.
21. Rudland, P. S., Hughes, C. M., Ferns, S. A., and Warburton, M. J. Characterisation of human mammary cell types in primary culture: immunofluorescent and immunocytochemical indicators of cellular heterogeneity. In Vitro Cell Dev. Biol., 25: 23-36, 1989.
22. Ke, Y., Fernig, D. G., Wilkinson, M. C., Smith, J. A., Rudland, P. S., and Barraclough, R. The expression of basic fibroblast growth factor and its receptor in cell lines derived from normal human mammary gland and a benign mammary lesion. J. Cell. Sci., 106: 135-143, 1993.
23. Gleason, D. F., Mellinger, G. T., and the Veterans Administration Coroperative Urology Research Group. Predication of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J. Urol., 111: 58-64, 1974.
24. Watanabe, R., Fujji, H., Yamamoto, A., Hashimoto, T., Kameda, K., Ito, M., and Ono, T. Immunohistological distribution of cutaneous fatty acid-binding protein in human skin. J. Dermtol. Sci., 16: 17-22, 1997.
25. Davies, B. R., Barraclough, B., and Rudland, P. S. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines. Cancer Res., 54: 2785-2793, 1994.
26. Oates, A. J., Barraclough, R., and Rudland, P. S. Enhanced expression of the osteopontin gene in metastatic mammary epithelial-derived cell lines. Oncogene, 13: 97-104, 1997.
27. Davies, B. R., Davies, M. P. A., Gibbs, F. E. M., Barraclough, R., and Rudland, P. S. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene, 8: 999-1008, 1993.
28. Chen, H., Ke, Y., Barraclough, R., and Rudland, P. S. Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinima cell line. Oncogene, 14: 1581-1588, 1997.
29. Ke, Y., Beesley, C., Smith, P., Barraclough, R., Rudland, P. S., and Foster, C. S. Generation of metastatic variants by transfection of a nonmetastatic rat epithelial cell line with genomic DNA from rat prostate carcinoma cells. Br. J. Cancer, 77: 287-296, 1998.
30. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13: 9-22, 1999.
31. Bass, N. M. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int. Rev. Cytol., 111: 143-184, 1988.
32. Horrobin, D. F. Essential fatty acids in clinical dermatology. J. Am. Acad. Dermatol., 20: 1045-1052, 1989.
33. Østergaard, M., Rasmussen, H. H., Nielsen, H. V., Vorum, H., Ørntoft, T. F., Wolf, H., and Celis, J. E. Protein profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res., 57: 4111-4117, 1997.
34. Masouye, I., Hagens, G., Van Kuppevelt, T. H., Madsen, P., Saurat, J. H., Veerkamp, J. H., Pepper, M. S., and Siegenthaler, G. Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein. Circ. Res., 81: 297-303, 1997.
35. Celis, J. E., Ostergaard, M., Basse, B., Celis, A., Lauridsen, J. B., Ratz, G. P., Andersen, I., Hein, B., Wolf, H., Orntoft, T. F., and Rasmussen, H. H. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res., 56: 4782-4790, 1996., 1996.
36. Celis, A., Rasmussen, H. H., Celis, P., Basse, B., Lauridsen, J. B., Ratz, G., Hein, B., Ostergaard, M., Wolf, H., Orntoft, T., and Celis, J. E. Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities. Electrophoresis, 20: 355-361, 1999.
37. Glatz, J. F. C., and Van der Vusse, G. J. Fatty acids in cell signalling. Prostaglandins Leukotrienes Essent. Fatty Acids, 57: 1, 1997.
38. Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., Kliewer, S. A., and Milburn, M. V. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell, 3: 397-403, 1999.
39. Lefebvre, A. M., Chen, I. H., Desreumaux, P., Najib, J., Fruchart, J. C., Geboes, K., Briggs, M., Heyman, R., and Auwerx, J. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumours in C57BL/6J-APC(Min)/+ mice. Nat. Med., 4: 1053-1057, 1998.
40. Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., U. T. M., Baird, S. M., Thomazy, V. A., and Evans, R. M. Activators of the nuclear receptor PPAR γ enhance colon polyp formation. Nat. Med., 4: 1058-1061, 1998.
41. Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., and Spiegelman, B. M. Differentiation and reversal of malignant changes in colon cancer through PPAR γ. Nat. Med., 4: 1046-1052, 1998.
42. Ota, S., Kato, A., and Matsuzaki, F. PPAR-γ agonist stimulates vascular endothelial growth factor (VEGF) production by human macrophages. Gastroenterology, 116: G2117, 1999.
43. Yang, G., Truong, L. D., Timme, T. L., Ren, C. Z., Wheeler, T. M., Park, S. H., Nasu, Y., Bangma, C. H., Kattan, M. W., Scardino, P. T., and Thompson, T. C. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res., 4: 1873-1880, 1998.